NuPathe's Seed VC Round

NuPathe raised a round of funding on November 11, 2005. Investors include BioAdvance.

NuPathe is a specialty pharmaceutical company developing therapeutic products for the treatment of neurological and psychiatric diseases. NuPathe's product portfolio includes NP101, which will be a t…

Articles about NuPathe's Seed VC Round: